NUZOLVENCE
NDC 68547-915, zoliflodacin, for suspension, from La Jolla Pharmaceutical Company.
- Product NDC
- 68547-915
- Status
- Listed
- Labeler
- La Jolla Pharmaceutical Company
- Dosage form
- FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219491
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68547-915 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZOLIFLODACIN3 g/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68547-915-10 | 68547091510 | 1 PACKET in 1 CARTON (68547-915-10) / 1 FOR SUSPENSION in 1 PACKET |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/4beda35a-21b0-4b34-84ea-be6ea8cae50f
Use it
Look up 68547-915 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68547-915 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68547-915. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.